We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
19.00 | 1.07% | 1,799.50 | 1,796.00 | 1,796.50 | 1,799.50 | 1,780.00 | 1,784.00 | 9,804,173 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 15.00 | 73.94B |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2018 09:35 | abdulla stick to your own rubbish shares | billionaire1 | |
01/2/2018 19:27 | If the market as a correction, investors run to defensive stocks, Pharma's not telecom. | montyhedge | |
01/2/2018 15:44 | Sell GSK down .5%and buy Vodafone down nearly 6% . | abdullla | |
01/2/2018 14:30 | Dow went up 5000 points in a matter of few weeks,if it loses the same way then we will see a CRASH never seen before! | abdullla | |
01/2/2018 14:15 | Yes, but looks like the US markets are starting a serious downturn - and that will likely affect everywhere else | hosede | |
01/2/2018 11:37 | Topped up, gift from Trump at this price. Finals next couple of weeks, div 23p forecast. That will do me. | montyhedge | |
01/2/2018 10:09 | He's got a bigger mouth than Emma .... ;0) | tradermichael | |
31/1/2018 23:22 | Market report: Pharma stocks slide as Donald Trump vows to tackle high drug prices | philanderer | |
31/1/2018 17:31 | Huge 4.4m share buy late in the day. Somebody still likes them. | ygor705 | |
31/1/2018 17:12 | I sold at 1330 | juju44 | |
31/1/2018 17:05 | Pity you two didn't think about selling it higher up. Better luck next time. Lost the big divi too unless you're back in the next 3 weeks. | woodhawk | |
31/1/2018 16:29 | Jumped ship too . No recovery in sight | juju44 | |
31/1/2018 16:27 | Sold out at 1318. May be OK long term, but it's going to go lower short term, I think | hosede | |
31/1/2018 14:39 | More damage now that the Dow is up,LSE is indeed a shift market! | abdullla | |
31/1/2018 09:04 | with thanks to henryatkin on SHA bb food for thought | ttg100 | |
30/1/2018 14:18 | Of course it's typical that despite some of the FTSE doing well, the whole FTSE will feel pain when the DJ does eventually correct. | romeike | |
30/1/2018 14:18 | News expected this week from Pfizer re: received bids on its consumer unit. Willing to guess EW has put in a low ball bid. Not sure about the RB interest, maybe a bid from Nestle or similar will surprise. | romeike | |
30/1/2018 14:03 | Dow up 5000 over last few months but hardly any improvement in ftse,now Dow down slightly and ftse going to kill itself ! | abdullla | |
30/1/2018 11:11 | The hike in VIX index, if sustained, may suggest a rotation is on the cards. | romeike | |
30/1/2018 08:12 | Rotation back into big pharma, perhaps. | montyhedge | |
29/1/2018 12:42 | Hike in Pfizer could suggest interest in big pharma is returning, we will have to see if the trend reverses for the benefit of holders here. A recent uptick in M&A can only be helpful in luring more funds back into the sector and away from Finance and Tech where valuations are currently stratospheric - yes, I am looking at you Netflix. | romeike | |
27/1/2018 18:23 | Prion disease = Alzheimers, motor neuron , parkinson's and more Dementia = human shakes disease The next BIG thing to come from the USA will be that CWD from deer has infected humans with a CJD type disease CWD and Prion disease are terminal = no cure Alzheimer's disease & dementia January 9, 2018 An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National Academy of Sciences, the group describes their study of sliced brain fragments and what they learned about the nature of amyloid-beta prions. Prior research has found a connection between protein clumps in the brain and Alzheimer's disease. Prior research has also shown that the protein clumps are a mutant type of amyloid beta, which results in the growth of plaques in the brain. In this new effort, the researchers have found evidence indicating that there are distinct types of amyloid-beta prion strains which can be associated with different types of brain diseases. The study consisted of dissecting and studying the brains of 41 patients who had died of Alzheimer's disease. Slices of brain tissue were doused with a fluorescent dye known to bind to amyloid bindings. The researchers studied the samples with confocal spectral imaging. Doing so, the group reports, revealed different types of disease associations between unique amyloid-beta prion strains. The researchers also found evidence that suggested mutant amyloid-beta can take on the self-propagating structure of prions, in which they form more self-replicating prions. One of the goals of research surrounding Alzheimer's disease and other dementia ailments is to find a way to diagnose the particular ailment so that it can be treated with drugs or other therapies specifically designed for it. Currently, the only way to accurately diagnose Alzheimer's disease is to study the brain after a patient has died. The researchers with this new effort suggest their findings are a step toward this goal. They further suggest that probes of the future might be sensitive enough to distinguish the different strains they have seen in their work, which would allow doctors to design treatments specifically suited to individual patients. There is no cure for Alzheimer's disease, but there are drugs that can slow its progression—th | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions